Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew site revision entry v3.7.0 was added to the history, replacing the previous v3.6.6. This reflects an interface/version update in the study history timeline.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study record history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This reflects an update to the ClinicalTrials.gov record display for the nct03836066 page.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry v3.6.5 is added to the study record history, superseding the previous v3.6.4.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.6.4 is added to the history. The previous v3.6.3 is removed from the list, updating the page's version history.SummaryDifference0.1%

- Check97 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study record's version history, and the previous revision v3.6.2 was removed, updating the historical record for the study.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision label v3.6.2 was added to the study record history, and the older v3.6.0 entry was removed from the log.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.